By: Arkadi Mazin
Six different aging clocks detected younger blood protein profiles in patients taking the experimental lung-fibrosis drug rentosertib.
Arkadi Mazin is a Science Journalist at Lifespan.io. He focuses on themes related to medicine and healthcare, with a particular emphasis on aging and longevity, diet and nutrition, fitness, and wellness programs. Arkadi's work has been featured in The Times of Israel and Lifespan.io, highlighting his commitment to exploring innovative approaches to health and wellness.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Arkadi Mazin's coverage heavily focuses on scientific topics, particularly longevity, aging, health, and research. His articles predominantly cite data and are likely to value pitches supported by robust empirical evidence or expert analysis.
Given the prevalence of data citation in his work, Arkadi may be more receptive to pitches from experts who can provide statistical insights or share new research findings related to longevity and aging.
As there is no specific geographic focus mentioned for Arkadi's coverage, he may cover global scientific developments within the field of longevity and aging. When reaching out to him with a pitch, consider providing international perspectives or studies that have broader implications beyond a single region.
This information evolves through artificial intelligence and human feedback. Improve this profile .